Searched for
SUN PHARMA Q4
Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...- Residential sales dip to lowest since Jan 2023 amid West Asia war, impacting buyer sentimentResidential sales in India experienced a significant dip in April-June, reaching the lowest point since early 2023. Geopolitical tensions a...
- Quote of the Day by Sun Tzu: "Place your army on death ground, and it will survive; plunge it into desperate straits, and it will..." — Ultimate life lessons on winning the war: The Art of War reveals why your greatest victories begin when retreat is impossibleQuote of the Day by Sun Tzu explores one of history's most enduring lessons on courage, commitment, and human psychology. In Chapter 11 of ...
- Q1 earnings preview: Here’s what Nomura expects from Nestle, Titan, other consumer majors’ June quarter resultsNomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...
- Goldman Sachs upgrades India's growth outlook after US-Iran peace dealGoldman Sachs has raised India's 2026 real GDP growth forecast to 6.8% from 6.5%, citing lower oil prices, easing supply disruptions and re...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Alera Group data breach settlement: Americans could get up to $3,500 in settlement payouts-know who’s eligible and the claim deadlineA significant data breach settlement from Alera Group Inc. offers thousands of Americans a chance for compensation, with a filing deadline ...
- India's office market remains cautious despite resilient demand and selective rental gains: ReportIndia's office market saw demand outpace new supply in Q2 FY26, leading to modest rent increases in active areas. Despite a cautious overal...
- Capricorn ♑ July 2026 Horoscope, Monthly Predictions: Delays Could Lead to Bigger Rewards Than Expected♑ Capricorn Monthly Horoscope (1st July 2026 to 31st July 2026): The Capricorn Monthly Horoscope indicates a month focused on work and pers...
- Leo ♌ July 2026 Horoscope, Monthly Predictions: Something Big Is Brewing Behind the Scenes, A Major Comeback Is Closer Than You Think♌ Leo Monthly Horoscope (1st July 2026 to 31st July 2026): The Leo Monthly Horoscope indicates a month of inner reflection. The Sun remains...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
- PSU banks lose gold loan sourcing share as private banks, NBFCs gain traction: ReportPublic sector banks are losing ground in the gold loan market to private lenders and NBFCs, which offer faster service and wider reach. Whi...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
